Cargando…
Identifying and revealing different brain neural activities of cognitive subtypes in early course schizophrenia
BACKGROUND: Cognitive subtypes of schizophrenia may exhibit different neurobiological characteristics. This study aimed to reveal the underlying neurobiological features between cognitive subtypes in the early course of schizophrenia (ECS). According to prior studies, we hypothesized to identify 2–4...
Autores principales: | Shao, Tiannan, Wang, Weiyan, Hei, Gangrui, Yang, Ye, Long, Yujun, Wang, Xiaoyi, Xiao, Jingmei, Huang, Yuyan, Song, Xueqin, Xu, Xijia, Gao, Shuzhan, Huang, Jing, Wang, Ying, Zhao, Jingping, Wu, Renrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577612/ https://www.ncbi.nlm.nih.gov/pubmed/36267704 http://dx.doi.org/10.3389/fnmol.2022.983995 |
Ejemplares similares
-
Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial
por: Xiao, Jingmei, et al.
Publicado: (2021) -
Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex
por: Shao, Tiannan, et al.
Publicado: (2023) -
Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
por: Kang, Dongyu, et al.
Publicado: (2018) -
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials
por: Huang, Jing, et al.
Publicado: (2022) -
Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial
por: Liu, Chenchen, et al.
Publicado: (2021)